Where Curiosity Meets the Right Information

Monday , 19 January 2026

Where Curiosity Meets the Right Information

Monday , 19 January 2026
Brand UpdatesLatest Happenings

Denmark’s IFU Commits $12.5 Million To Expand AKS Khan Pharmaceuticals

Share
Denmark’s IFU Commits $12.5 Million To Expand AKS Khan Pharmaceuticals
Share

In a significant boost to healthcare infrastructure in Bangladesh, Denmark’s Investment Fund for Developing Countries (IFU) has pledged $12.5 million to AKS Khan Pharmaceuticals. The investment aims to expand the pharmacy chain’s network, enabling it to serve 8 million patients annually within the next three years reportedly.

The agreement was formalized during a ceremony at the Radisson Blu Water Garden Hotel in Dhaka. AK Shamsuddin Khan, Director of AK Khan & Company Limited, and Lars Bo Bertram, CEO of the IFU, signed the deal.

The expansion plan is spearheaded by Samanzar S Khan, Managing Director of AKS Khan Holdings. The company aims to establish a network of 100 pharmacies and diagnostic centers, marking a significant leap from its current reach of 1.5 million patients per year.

Read more: Renata Begins Export Of Psychiatric Medicines To The US

They strive to deliver high-quality, genuine medicines to millions, ensuring effective treatment and enhancing the quality of life for individuals living with chronic illnesses throughout Bangladesh.

Christian Brix Møller, the Danish ambassador to Bangladesh, praised the initiative, describing it as a vote of confidence in Bangladesh’s progress during its transitional period and stated that the investment reflects trust in the interim government’s efforts and the country’s potential for sustained growth.

Since 1990, the IFU has invested €300 million in various Bangladeshi projects, including a fertilizer company and a water treatment facility in Dhaka. Lars Bo Bertram emphasized IFU’s focus on impact investments that foster economic and social development while delivering financial returns.

It is also expressed that the initiative underscores the commitment to making a tangible difference in the lives of millions while ensuring sustainable growth.

With this ambitious expansion, AKS Khan Pharmaceuticals is poised to transform healthcare accessibility in Bangladesh, reaffirming its role as a critical player in the nation’s healthcare ecosystem.

For more updates, be with Markedium.

Share

Leave a comment

Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Related Articles
MetLife Invests BDT 50 Crore in Bangladeshs First Ever Social Bond Issued by BRAC Bank
Brand Updates

MetLife Invests BDT 50 Crore in Bangladesh’s First-Ever Social Bond Issued by BRAC Bank

MetLife Bangladesh has invested BDT 50 crore in the country’s first-ever social...

BRAC Bank Introduces Scholarship Support for Employees Children with Disabilities
Brand Updates

BRAC Bank Introduces Scholarship Support for Employees’ Children with Disabilities

BRAC Bank has introduced a scholarship programme to support the education of...

BRAC University Entrepreneurship Development Forum BUEDF Hosted Undergrad Startup Challenge 2025
Latest Happenings

BRAC University Entrepreneurship Development Forum (BUEDF) Hosted Undergrad Startup Challenge 2025

𝗕𝗥𝗔𝗖 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 𝗘𝗻𝘁𝗿𝗲𝗽𝗿𝗲𝗻𝗲𝘂𝗿𝘀𝗵𝗶𝗽 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗙𝗼𝗿𝘂𝗺 (𝗕𝗨𝗘𝗗𝗙) hosted  𝗚𝗿𝗮𝗻𝗱 𝗙𝗶𝗻𝗮𝗹𝗲 of 𝗨𝗻𝗱𝗲𝗿𝗴𝗿𝗮𝗱 𝗦𝘁𝗮𝗿𝘁𝘂𝗽...

MetLife Bangladesh Recognizes Best Insurance Agency for 2025
Brand Updates

MetLife Bangladesh Recognizes Best Insurance Agency for 2025

MetLife Bangladesh has recently honored the country’s best insurance agency. For the...